Back to News
Market Impact: 0.28

Guru Fundamental Report for ACN

ACNBRK.ABRK.BNDAQ
Company FundamentalsCorporate EarningsCapital Returns (Dividends / Buybacks)Analyst InsightsManagement & Governance
Guru Fundamental Report for ACN

Validea’s guru fundamental report ranks Accenture (ACN) highly under its Patient Investor (Warren Buffett) model, awarding a 93% score and making it the top-rated stock across the firm’s 22 strategy models; ACN passes the model’s key Buffett-style screens—including earnings predictability, debt service, return on equity and total capital, free cash flow, disciplined use of retained earnings, and share repurchases—signaling predictable profitability, low leverage and shareholder-friendly capital allocation. The finding suggests Accenture merits consideration as a long-term, quality core holding for value-oriented institutional investors, though the report does not provide specific price targets or valuation metrics.

Analysis

Validea’s guru fundamental report ranks Accenture (ACN) highest under its Patient Investor model based on Warren Buffett’s published strategy, assigning a 93% score among 22 guru strategies and noting that scores above 90% indicate strong interest. The model explicitly targets firms with long-term predictable profitability and low debt; Validea classifies ACN as a large-cap growth company in the Computer Services industry. ACN passes the strategy’s key screens—earnings predictability, debt service, return on equity, return on total capital, free cash flow, disciplined use of retained earnings, and share repurchases—signaling a combination of sustainable profitability, low leverage and shareholder-friendly capital allocation. These attributes align with a Buffett-style quality filter that prioritizes durable returns and conservative balance-sheet management. Supplementary signals show moderately positive sentiment (overall 0.65, ACN 0.7) and a low estimated market-impact score (0.28), implying favorable perception but limited short-term catalyst from the report itself. The research is model-driven and provides no price targets or valuation multiples; investors should therefore treat this as a quality confirmation rather than a timing or valuation recommendation.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.